Market Value5,131,829,000
Total Holdings57
File Date2020-08-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
STRO / Sutro Biopharma, Inc.
TVTX / Travere Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
ARYBU / ARYA Sciences Acquisition Corp II
AVDL / Avadel Pharmaceuticals plc
OVID / Ovid Therapeutics Inc.
0PP / Portola Pharmaceuticals Inc
VCEL / Vericel Corporation
US74140Y1010 / Prevail Therapeutics Inc.
SELB / Selecta Biosciences Inc
QURE / uniQure N.V.
EXEL / Exelixis, Inc.
NVCR / NovoCure Limited
CGEN / Compugen Ltd.
US60877T1007 / Momenta Pharmaceuticals, Inc.
US28249H1041 / Eidos Therapeutics, Inc.
AXSM / Axsome Therapeutics, Inc.
RARX / Ra Pharmaceuticals, Inc.
CNCE / Concert Pharmaceuticals Inc
ADVM / Adverum Biotechnologies, Inc.
LYRA / Lyra Therapeutics, Inc.
TGTX / TG Therapeutics, Inc.
RYTM / Rhythm Pharmaceuticals, Inc.
OCUL / Ocular Therapeutix, Inc.
PASG / Passage Bio, Inc.
ARQT / Arcutis Biotherapeutics, Inc.
ARVN / Arvinas, Inc.
PHAT / Phathom Pharmaceuticals, Inc.
SNDX / Syndax Pharmaceuticals, Inc.
EPIX / ESSA Pharma Inc.
AKUS / Akouos Inc
GRTX / Galera Therapeutics, Inc.
PCVX / Vaxcyte, Inc.
VSTM / Verastem, Inc.
RLMD / Relmada Therapeutics, Inc.
GILD / Gilead Sciences, Inc.
LRMR / Larimar Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
ADAP / Adaptimmune Therapeutics plc - Depositary Receipt (Common Stock)
CRNX / Crinetics Pharmaceuticals, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
SLDB / Solid Biosciences Inc.
ARDX / Ardelyx, Inc.
NVAX / Novavax, Inc.
XFOR / X4 Pharmaceuticals, Inc.
CCXI / ChemoCentryx Inc
KROS / Keros Therapeutics, Inc.
IMGN / ImmunoGen, Inc.
ZGNX / Zogenix Inc
IMRA / Bitwise Funds Trust - Bitwise MARA Option Income Strategy ETF
RPTX / Repare Therapeutics Inc.
STSA / Satsuma Pharmaceuticals Inc
TRIL / Trillium Therapeutics Inc
GERN / Geron Corporation
ALEC / Alector, Inc.
SCPH / scPharmaceuticals Inc.
FMTX / Forma Therapeutics Holdings Inc
CLDX / Celldex Therapeutics, Inc.
KALA / KALA BIO, Inc.
INSM / Insmed Incorporated
ETNB / 89bio, Inc.
MGNX / MacroGenics, Inc.
LEGN / Legend Biotech Corporation - Depositary Receipt (Common Stock)
BDTX / Black Diamond Therapeutics, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
WVE / Wave Life Sciences Ltd.